Treating obesity in type 1 diabetes mellitus – review of efficacy and safety
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-12
DOI
10.1097/med.0000000000000841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of tirzepatide in a patient with type 1 diabetes and obesity: A case report
- (2023) Francine Mendoza et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Real-world Evidence of Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
- (2022) Ana Palanca et al. DIABETES CARE
- Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus
- (2022) Amelia S Wallace et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
- (2022) Khary Edwards et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
- (2022) Nuha A. ElSayed et al. DIABETES CARE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials
- (2021) Z. Fang et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes
- (2021) Signe Schmidt et al. DIABETES OBESITY & METABOLISM
- Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT ‐2 study): 52‐week results from a randomized controlled trial
- (2020) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- Vascular and metabolic effects of metformin added to insulin therapy in patients with type 1 diabetes: A systematic review and meta‐analysis
- (2020) Ying‐Shan Liu et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study
- (2020) Gudrun Höskuldsdóttir et al. DIABETES CARE
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study
- (2019) Antonio Alderisio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis
- (2019) Christian Hampp et al. DIABETES CARE
- Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial
- (2019) Thomas F. Dejgaard et al. DIABETES OBESITY & METABOLISM
- Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review
- (2018) Jessica L. Turton et al. PLoS One
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one-year retrospective matched cohort study
- (2018) Adham Mottalib et al. DIABETES OBESITY & METABOLISM
- Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
- (2018) Paresh Dandona et al. DIABETES CARE
- Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
- (2018) Julio Rosenstock et al. DIABETES CARE
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
- (2017) Satish K. Garg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
- (2016) Bo Ahrén et al. DIABETES CARE
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
- (2016) Chantal Mathieu et al. DIABETES CARE
- Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery
- (2016) Nuria Vilarrasa et al. OBESITY SURGERY
- Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
- (2016) Maurizio De Luca et al. OBESITY SURGERY
- Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus
- (2016) Christian Seerup Frandsen et al. Lancet Diabetes & Endocrinology
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
- (2015) Philip D. Home et al. DIABETES CARE
- Efficacy and Safety of Metformin for Patients with Type 1 Diabetes Mellitus: A Meta-Analysis
- (2015) Cong Liu et al. Diabetes Technology & Therapeutics
- Prevalence of Low Testosterone and Predisposing Risk Factors in Men With Type 1 Diabetes Mellitus: Findings From the DCCT/EDIC
- (2014) Sarah K. Holt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus
- (2013) Hsin-Chieh Yeh et al. ANNALS OF INTERNAL MEDICINE
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Incretins: Their physiology and application in the treatment of diabetes mellitus
- (2013) Hale M. Tasyurek et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Children younger than 7 years with type 1 diabetes are less physically active than healthy controls
- (2012) F Sundberg et al. ACTA PAEDIATRICA
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
- (2012) John B Buse et al. LANCET
- Obesity and Coronary Artery Calcium in Diabetes: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study
- (2011) Ticiana C. Rodrigues et al. Diabetes Technology & Therapeutics
- Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration
- (2009) ARCHIVES OF INTERNAL MEDICINE
- The role of amylin in the physiology of glycemic control
- (2009) W. A. Scherbaum EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study
- (2009) Lenna L Liu et al. PEDIATRIC DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started